Galapagos creates new warrant plan
(Thomson Reuters ONE) -
Mechelen, Belgium; 7 February 2011 - Galapagos NV (Euronext: GLPG) announced
today that its Board of Directors has created and offered 75,000 warrants under
a new warrant plan.
Since its inception in 1999, Galapagos has used warrant plans to allow personnel
and management to be involved in the company's growth and development. On 23
December 2010 the Board of Directors of Galapagos approved "Warrant Plan 2010
(C)" within the framework of the authorized capital. Under this new warrant
plan 75,000 warrants were offered to Dr Radan Spaventi, who joined Galapagos'
Executive Committee as Senior Vice President following the Group's acquisition
of the Zagreb unit in September 2010. These warrants have an exercise price of
?11.74 per warrant (30 days average closing price prior to offer date 23
December 2010) and an exercise period of eight years starting as of the offer
date. The acceptance of these warrants and their issuance was established by
notary deed of 24 January 2011.
The warrants are not transferable and cannot be exercised prior to the end of
the third calendar year after the year in which they were granted. Each warrant
gives the right to subscribe to one new Galapagos share. Should the warrants be
exercised, Galapagos will apply for the listing of the resulting new shares on a
regulated stock market. The warrants as such will not be admitted to listing on
any stock market.
To date, Galapagos' total share capital amounts to ?142,590,770.44; the total
number of securities conferring voting rights is 26,358,984, which is also the
total number of voting rights (the "denominator"); all securities conferring
voting rights and all voting rights are of the same category. The total number
of rights (warrants) to subscribe to not yet issued securities which confer
voting rights is 2,730,153, which is also the total number of voting rights that
may result from the exercise of these warrants. Galapagos does not have
outstanding any in voting securities convertible bonds nor shares without voting
rights.
About Galapagos
Galapagos (Euronext: GLPG; OTC: GLPYY) is a mid-size biotechnology company
specialized in the discovery and development of small molecule and antibody
therapies with novel modes-of-action. The Company is progressing one of the
largest pipelines in biotech, with seven clinical and over 50 discovery
programs. Through risk/reward-sharing alliances with GlaxoSmithKline, Lilly,
Janssen Pharmaceutica, Roche and Servier, Galapagos is eligible to receive up to
?2.5 billion in downstream milestones, plus royalties. The Galapagos Group has
over 800 employees and operates facilities in seven countries, with global
headquarters in Mechelen, Belgium. More info at: www.glpg.com
CONTACT
Galapagos NV
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240
ir(at)glpg.com
This release may contain forward-looking statements, including, without
limitation, statements containing the words "believes," "anticipates,"
"expects," "intends," "plans," "seeks," "estimates," "may," "will," "could,"
"stands to," and "continues," as well as similar expressions. Such forward-
looking statements may involve known and unknown risks, uncertainties and other
factors which might cause the actual results, financial condition, performance
or achievements of Galapagos, or industry results, to be materially different
from any historic or future results, financial conditions, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, the reader is advised not to place any undue reliance on
such forward-looking statements. These forward-looking statements speak only as
of the date of publication of this document. Galapagos expressly disclaims any
obligation to update any such forward-looking statements in this document to
reflect any change in its expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is based, unless
required by law or regulation.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE
[HUG#1486121]
Unternehmensinformation / Kurzprofil:
Datum: 07.02.2011 - 18:00 Uhr
Sprache: Deutsch
News-ID 51160
Anzahl Zeichen: 5087
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Galapagos creates new warrant plan"
steht unter der journalistisch-redaktionellen Verantwortung von
Galapagos NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
